Vical Incorporated (NASDAQ:VICL) Investor Alert: Lawsuit Alleges Securities Laws Violations
An investor, who purchased shares of Vical Incorporated (NASDAQ:VICL), filed a lawsuit in the U.S. District Court for the Southern District of California over alleged violations of Federal Securities Laws by Vical Incorporated in connection with certain allegedly false and misleading statements made between February 8, 2012 and August 12, 2013 over its immunotherapy vaccine Allovectin-7.
View full press release